Kathryn M. Moore

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

Venkata-Viswanadh Edara, Kelly E. Manning, Madison Ellis et al. · Cell Reports Medicine · 2022 · 215 citations · Full text

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

Kirsten E. Lyke, Robert L. Atmar, Clara Domínguez Islas et al. · Cell Reports Medicine · 2022 · 165 citations · Full text

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization

Nicole A. Doria‐Rose, Xiaoying Shen, Stephen D. Schmidt et al. · 2021 · 129 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +15

Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south

Paula M. Frew, Julia E. Painter, Brooke Hixson et al. · Vaccine · 2012 · 72 citations

Vaccination, Preventive Medicine, Diverse Populations +9

Synergistic drug combinations for a precision medicine approach to interstitial glioblastoma therapy

Elizabeth G. Graham-Gurysh, Ananya B. Murthy, Kathryn M. Moore et al. · Journal of Controlled Release · 2020 · 68 citations · Full text

Neuro-oncology, Synergistic Drug Combinations, Interstitial Glioblastoma Therapy +11